bullish
Progyny (PGNY US): Initial 2022 Guidance Issued After Record Number of New Clients Added
Tina has highlighted this Insight as a Top Pick
171 Views09 Nov 2021 21:53
SUMMARY
- Progyny Inc (PGNY US) shares touched new high after the company issued 2022 revenue growth guidance of 50%. The company has added record high number of new clients and new covered lives.
- The company reported Q3 revenue of $122.3 million (+24% y/y), in-line with guidance of $120–130 million. EPS grew 240% y/y to $0.17, 183% ahead of consensus of $0.06. Progyny expects 2021 revenue growth of 47–49% y/y.
- Investors can add to positions as Progyny is expected to be on a high growth trajectory as the company is still just 2% penetrated in its addressable market of 8,000 self-insured employers in the U.S., leaving enough growth opportunity.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Progyny (PGNY US): Q2 Results Ahead of Expectations; 2022 Guidance Raised Second Time This Year12 Aug 2022
- Progyny (PGNY US): Stellar Q4 Results; 2022 Guidance Reiterated on the Back of Business Recovery05 Mar 2022
- Progyny (PGNY US): Initial 2022 Guidance Issued After Record Number of New Clients Added09 Nov 2021
x